-
Mitt Romney urges his donors to coalesce behind one challenger to Trump
“We don’t know what we are or what we stand for within our party,” the Republican senator said to a gathering of influential donors.
-
Scalise, Jordan make final pitches as House Republicans’ speaker vote looms
The moderate faction of the House Republican conference worked to exert its influence after feeling beholden to hardliners’ whims in recent months.
-
CISA Releases Advisory Concerning Chinese-Backed Threat Actor
On September 27, 2023, The U.S. National Security Agency (NSA), the U.S. Federal Bureau of Investigation (FBI), the U.S. Cybersecurity and Infrastructure Security Agency (CISA), the Japanese National Police Agency (NPA), and the Japanese National Center of Incident Readiness and Strategy for Cybersecurity (NISC) released a joint cybersecurity advisory (CSA) concerning the recent activity of…
-
Purdue Pharma L.P. v. Accord Healthcare Inc. OxyContin® (Oxycodone HCl)
Case Name: Purdue Pharma L.P. v. Accord Healthcare Inc., No. 20-1362-RGA, 2023 WL 2894939 (D. Del. Apr. 11, 2023) (Andrews, J.) Drug Product and Patent(s)-in-Suit: OxyContin® (oxycodone HCl); U.S. Patents Nos. 9,763,933 (“the ’63933 patent”), 9,775,808 (“the ’808 patent”), and 9,763,886 (“the ’886 patent”), collectively “the Abuse-Deterrent patents,” 9,073,933 (“the ’73933 patent”), and 9,522,919 (“the…
-
MOVEIt MDL – Putting the Transfer Order Into Action
On October 4, 2023, the Joint Panel on Multidistrict Litigation (JPML) issued a Transfer Order consolidating certain actions relating to a vulnerability in Progress Software’s MOVEit file transfer software which was exploited by a Russian cybergang in May 2023….By: BakerHostetler
-
DEA Extends Telemedicine Flexibilities for Prescribing of Controlled Medications: Second Time is the Charm
On October 6, 2023, the Drug Enforcement Administration (DEA) released a second temporary rule extending the COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. This second extension, issued shortly after DEA’s listening session on a potential new Telemedicine Special Registration, gives practitioners and patients certainty of the DEA requirements for telemedicine prescribing through the end…
-
Generative AI: Investigations Watch
Generative AI has captured the world’s attention, and regulators are no exception. Indeed, the FTC and other regulators are increasingly active on multiple fronts—from large scale antitrust enforcement efforts, to issues as small as online subscriptions and customer reviews. When it comes to generative AI, recent developments suggest that these same regulators are intent on…
-
University Federal Credit Union Confirms Over 100k Customers Affected by MOVEit Data Breach
On October 10, 2023, the University Federal Credit Union (“UFCU”) filed a notice with the Attorney General of Maine after discovering that one of the company’s vendors experienced a data breach affecting UFCU customers. In this notice, UFCU explains that the incident resulted in an unauthorized party being able to access consumers’ sensitive information, which…
-
23andMe Experiences Data Breach Following Credential Stuffing Attack
On October 6, 2023, 23andMe confirmed reports that the company experienced a data breach affecting customer’s sensitive information. Based on statements from the company and various third-party news outlets, it appears that the incident stemmed from a credential stuffing attack. However, 23andMe denied that the company itself had been hacked….By: Console and Associates, P.C.
-
Walmart, Inc. Files Notice of Data Breach with the HHS-OCR, Indicating Over 85k Victims
On October 4, 2023, Walmart, Inc. filed a notice of data breach with the U.S. Department of Health and Human Services Office for Civil Rights after discovering that an unauthorized party had gained access to information that had been entrusted to the company. While Walmart’s recently filed notice does not explain the specific data types…
